Kalos Management’s Avery Dennison AVY Stock Holding History

Kalos Management’s Portfolio AVY Stock Details AVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,862	Closed	-$840K	–	166
2018 Q2	$840K	Buy	+7,862	New	+$831K	0.38%	72
2018 Q1	–	Sell	-7,254	Closed	-$833K	–	131
2017 Q4	$833K	Buy	7,254 +1,182	+19%	+$128K	0.39%	67
2017 Q3	$597K	Buy	+6,072	New	+$571K	0.38%	79

Other funds holding AVY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Homestead Advisers Arlington, Virginia $3.72B AUM 24.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kalos Management's AVY Position: Q3 2018 in Review

Kalos Management sold out of Avery Dennison (AVY) in Q3 2018, closing a stake of 7,862 shares — an estimated $840K sold.

Kalos Management first reported a position in AVY in Q3 2017 and held it in 3 quarters. The position peaked at $840K in Q2 2018. 573 funds tracked by Wall St. Rank hold AVY as of Q3 2018.

Kalos Management reported no remaining Avery Dennison position as of Q3 2018 after selling out during the quarter.
Kalos Management sold 7,862 Avery Dennison shares in Q3 2018, an estimated $840K.
Kalos Management first reported a position in Avery Dennison in Q3 2017 and held it in 3 quarters.
Kalos Management's Avery Dennison position peaked at $840K in Q2 2018.
573 funds tracked by Wall St. Rank held Avery Dennison as of Q3 2018.

Based on Kalos Management's 13F filing for Q3 2018, filed 14 Nov 2018.